SCHEMBL7825879

SCHEMBL7825879

COc1cc2[nH]cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2cc1OC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.76
CDK4 P11802 5/20 0.72
CCND1 P24385 5/20 0.72
FLT4 P35916 5/20 0.72
TEK Q02763 5/20 0.72
IGF1R P08069 4/20 0.72
PDGFRB P09619 4/20 0.72
KIT P10721 4/20 0.72
PDGFRA P16234 4/20 0.72
FLT1 P17948 4/20 0.72
CDK2 P24941 3/20 0.72
EGFR P00533 3/20 0.72
ERBB2 P04626 3/20 0.72
GSK3B P49841 3/20 0.72
ABL1 P00519 2/20 0.72
PLK4 O00444 2/20 0.72
AURKA O14965 2/20 0.72
NUAK1 O60285 2/20 0.72
SRC P12931 2/20 0.72
FLT3 P36888 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL9086300 0.88 KDR (0.61) KDRCDK4CCND1FLT4TEK
SCHEMBL7814853 0.87 KDR (0.58) KDRCDK4CCND1FLT4TEK
SCHEMBL1155008 0.86 KDR (1.00) KDRCDK4CCND1FLT4TEK
SCHEMBL7825953 0.85 SIRT2 (0.72) KDRCDK4CCND1FLT4TEK
SCHEMBL7815879 0.84 CDK4 (0.73) KDRCDK4CCND1FLT4TEK
SCHEMBL9085267 0.84 CDK4 (0.87) KDRCDK4CCND1FLT4TEK
Maleimide SCHEMBL1155440 0.84 KDR (1.00) KDRCDK4CCND1FLT4TEK
SCHEMBL9086343 0.83 PRKCB (0.67) KDRCDK4CCND1FLT4TEK
SCHEMBL9085502 0.83 PRKCB (0.67) KDRCDK4CCND1FLT4TEK
Ro-316233 SCHEMBL624896 0.83 PRKCB (1.00) KDRCDK4CCND1FLT4TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP claimed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US claimed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP claimed
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP disclosed
US-5516915-A Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US disclosed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP disclosed